IMTX (Immatics NV) Short Interest


IMTX Immatics NV IMTX
60 GF Score
Price $10.12
GF Value $3.57
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Immatics NV Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

IMTX vs INVA, PGEN, VIR: Short Interest Comparison

For the Biotechnology subindustry, Immatics NV's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immatics NV Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immatics NV's Short Interest distribution charts can be found below:

* The bar in red indicates where Immatics NV's Short Interest falls into.


IMTX
60GF Score
Immatics NV IMTX
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Immatics NV (IMTX) Overvalued in 2026?

Based on GuruFocus' analysis, Immatics NV stock appears to be overvalued. The current stock price of $10.12 is trading 183.5% above its estimated GF Value™ of $3.57. GuruFocus considers Immatics NV to be Significantly Overvalued.

Key valuation signals for IMTX:

  • Short Interest:
  • GF Value™: $3.57 vs. price of $10.12 (183.5% above fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the IMTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Immatics NV Business Description

Other Exchanges 4A3:Germany
Address Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
60GF Score

Get the complete analysis for IMTX

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.12
Price
$3.57
GF Value